HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Schumacher Selected Research

Sepsis (Septicemia)

5/2022N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes.
1/2017N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1.
5/2014The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Schumacher Research Topics

Disease

10Peripheral Nervous System Diseases (PNS Diseases)
10/2021 - 01/2014
9Pain (Aches)
03/2020 - 01/2014
5Breast Neoplasms (Breast Cancer)
01/2020 - 01/2018
4Neuralgia (Stump Neuralgia)
01/2020 - 01/2014
3Inflammation (Inflammations)
05/2022 - 01/2017
3Sepsis (Septicemia)
05/2022 - 05/2014
3Acute Pain
03/2020 - 01/2017
3Tinnitus
02/2018 - 01/2018
3Hearing Loss (Hearing Impairment)
02/2018 - 01/2018
2Postoperative Pain
01/2019 - 06/2018
2Chronic Pain
01/2017 - 01/2017
1Endotoxemia
05/2022
1Anastomotic Leak
10/2020
1Ileus
10/2020
1Hypesthesia (Numbness)
01/2019
1Hypersensitivity (Allergy)
01/2019
1Lung Neoplasms (Lung Cancer)
12/2018
1Back Pain (Backache)
06/2018
1Neoplasms (Cancer)
06/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Heart Arrest (Cardiac Arrest)
11/2014
1Respiratory Insufficiency (Respiratory Failure)
01/2014
1Unconsciousness (Loss of Consciousness)
06/2010
1Hyperalgesia
06/2010
1Mastocytosis
03/2004
1Prurigo
03/2004
1Pruritus (Itching)
03/2004

Drug/Important Bio-Agent (IBA)

5Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 01/2018
4Anesthetics (Anesthetic Agents)IBA
03/2020 - 06/2010
3Analgesics (Analgesic Drugs)IBA
03/2020 - 01/2017
2CytokinesIBA
05/2022 - 05/2014
2PlatinumIBA
01/2019 - 01/2018
2Complement System Proteins (Complement)IBA
01/2017 - 01/2017
2aminoalcoholphosphotransferase (AAPT)IBA
01/2017 - 01/2017
2Capsaicin (Zostrix)FDA Link
01/2014 - 03/2004
1Interleukin-10 (Interleukin 10)IBA
05/2022
1N-oleoyldopamineIBA
05/2022
1Biological FactorsIBA
03/2020
1Hypoxia-Inducible Factor 1IBA
01/2020
1Bortezomib (Velcade)FDA Link
01/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019
1Sp4 Transcription FactorIBA
01/2019
1Nerve Growth Factor (NGF)IBA
01/2019
1TinIBA
02/2018
1taxaneIBA
01/2018
1IronIBA
01/2018
1LipopeptidesIBA
01/2017
1LipidsIBA
01/2017
1Dopamine (Intropin)FDA LinkGeneric
01/2017
1Plasminogen Activator Inhibitor 1IBA
01/2017
1Lactic Acid (Lactate)FDA LinkGeneric
11/2014
1ChemokinesIBA
05/2014
1General AnestheticsIBA
06/2010
1CalciumIBA
06/2010
1IsofluraneFDA LinkGeneric
06/2010
1Irritants (Vesicants)IBA
06/2010
1Ion Channels (Ion Channel)IBA
06/2010
1Proteins (Proteins, Gene)FDA Link
03/2004
1Messenger RNA (mRNA)IBA
03/2004

Therapy/Procedure

9Drug Therapy (Chemotherapy)
10/2021 - 01/2018
1Colectomy
10/2020
1Pain Management
06/2018
1Infusion Pumps (Infusion Pump)
06/2018
1Spinal Fusion (Spondylosyndesis)
06/2018
1Patient-Controlled Analgesia (Analgesia, Patient Controlled)
06/2018
1Therapeutics
01/2014